# OnCo record idea-reg-new-indication-exclusivity-off-patent (idea). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/ideas/idea-reg-new-indication-exclusivity-off-patent/>
  a schema:CreativeWork ;
  onco:kind "idea" ;
  schema:identifier "idea-reg-new-indication-exclusivity-off-patent" ;
  schema:name "Three years of indication-specific exclusivity for proving a new cancer use of an old drug"@en ;
  schema:description "Nobody funds trials of old drugs because competitors can sell the result for free. A short exclusive period for the new use, like the one given for children's studies, would change that."@en ;
  schema:url <https://onco.cc/ideas/idea-reg-new-indication-exclusivity-off-patent/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:citation <https://doi.org/10.3332/ecancer.2014.442> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-generic-repurposing/>, <https://onco.cc/bottlenecks/b-incentive-misalignment/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-pantziarka-ecancermedicalscience/> .